# Cholestyramine for Oral Suspension

NDC: 62135-937
Generic name: Cholestyramine for Oral Suspension
Labeler / Manufacturer: Chartwell RX, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: POWDER
Routes: ORAL
Marketing started: 19960815

FDA application: ANDA074562

## Active ingredients

- CHOLESTYRAMINE: 4 g/5.7g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62135-937"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62135-937
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80db0042-0c05-4509-8a6b-fa9f4783629a